ESH 7th International Conference
ACUTE MYELOID LEUKEMIA “MOLECULAR AND TRANSLATIONAL”:
ADVANCES IN BIOLOGY AND TREATMENT
Save the date: October 16-18,2025 – Estoril, Portugal *
#ESHAML2025
Chairs: Bob Löwenberg, Hartmut Döhner, Benjamin Ebert
REGISTRATION & ABSTRACT SUBMISSION ARE OPEN!
ABOUT THE CONFERENCE:
The successful biannual ESH Conferences on acute myeloid leukemia (AML) have established themselves as scientific and educational programs at the interphase of molecular and biologic developments and clinical translation. Novel technological, molecular and immunologic approaches are rapidly creating novel insights into the biology and therapeutic perspectives of AML.
The cutting-edge program of the conference will deal with the molecular and functional features of leukemic stem cells and their interaction with the microenvironment, the role of somatic and germ-line mutations and epigenetic alterations in the biology of AML, the genomics of leukemogenesis, advances in molecular diagnostics and developmental therapeutics with a focus on molecular and immunotherapeutic targeted therapeutics. Special attention will be given to the utility and promise of novel therapeutic agents.
Words from the Conference Chairs:
“We wish to invite and encourage you to join us at the ESH AML meeting upcoming in 2025. These conferences have an outstanding record of talks from international leaders in the basic science and clinical treatment of leukemia along with robust discussions and many opportunities for interactions.
The seventh bi-annual conference in this series will offer discussions on the latest developments and emerging insights in the fascinating biology and rapidly changing clinical landscape of AML. For the attendees it holds the promise of another inspiring interactive experience.”
– Hartmut Döhner, Benjamin Ebert & Bob Löwenberg
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.
CONFERENCE MAIN SCIENTIFIC TOPICS:
• PREDISPOSITION AND AGING
• CLONAL HEMATOPOIESIS
• TARGETING CLONAL HEMATOPOIESIS
• THERAPEUTIC TARGETING 1
• METABOLIC AND PROTEOMIC ALTERATIONS
• CELLULAR THERAPY
• THERAPEUTIC TARGETING 2
• MEASURABLE RESIDUAL DISEASE IN AML
• THERAPEUTIC TARGETING 3
• THERAPEUTIC TARGETING 4
This meeting will be valuable to you if you are looking for:
– A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
– Multiple opportunities for scientific interaction with an international faculty of distinguished experts
– An emphasis on critical discussion
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.
The meeting will be of interest to:
– Ph-students, post docs, junior and senior biologists and practicing clinicians (MD, PhD, MD-PhD), hematologists and oncologists in training
– Residents and biologists still in training
The program will include:
• Plenary Sessions
• Panel Discussions
• Simultaneous Meet the Expert Sessions
• Poster Walks
• Ample time for in-depth discussion
* This conference is a Face to Face meeting. No virtual attendance is scheduled.
Click HERE to read the preliminary program!
CLICK HERE TO SUBMIT YOUR ABSTRACT!
DEADLINE FOR SUBMISSION OF ABSTRACTS FOR POSTER PRESENTATIONS: July 6th, 2025 (23:59 CEST)
Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 500
– Your abstract will be submitted to the peer review procedure.
The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).
We accept “encore” abstract.
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.
Click HERE to book accommodation at a preferential rate.
Warning!
We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link provided by ESH on this page, or directly with the hotel or renown booking services platform.
Estoril Congress Center
Av. Amaral,
2765-192 Estoril, Portugal
Estoril is located on the Portuguese coast at about a half hour drive from Lisbon International airport (https://www.airport-lis.com/)
With the support of*:
Emerald Conference Partner
*******
Ruby Conference Partner
*******
Supporting Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
The registration fee for the ESH 7th International Conference on AML is:
– 600€ for fully trained
– 300€ for in-training (a proof will be requested to confirm your status)
– 300€ for Allied Health Professionals
– 600€ for Corporate
ESH is pleased to offer BHS, BSH, DGHO, HSH, OeGHO, PTHiT, SEHH, SFH (French), SFH (Swedish) & SPH Members Members a 20% discount on the conference registration fees.
This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.
Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.